Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czech Republic.
First Faculty of Medicine, Charles University, Prague, Czech Republic.
J Enzyme Inhib Med Chem. 2022 Dec;37(1):515-526. doi: 10.1080/14756366.2021.2024527.
Cathepsin K (CatK) is a target for the treatment of osteoporosis, arthritis, and bone metastasis. Peptidomimetics with a cyanohydrazide warhead represent a new class of highly potent CatK inhibitors; however, their binding mechanism is unknown. We investigated two model cyanohydrazide inhibitors with differently positioned warheads: an azadipeptide nitrile and a 3-cyano-3-aza-β-amino acid . Crystal structures of their covalent complexes were determined with mature CatK as well as a zymogen-like activation intermediate of CatK. Binding mode analysis, together with quantum chemical calculations, revealed that the extraordinary picomolar potency of is entropically favoured by its conformational flexibility at the nonprimed-primed subsites boundary. Furthermore, we demonstrated by live cell imaging that cyanohydrazides effectively target mature CatK in osteosarcoma cells. Cyanohydrazides also suppressed the maturation of CatK by inhibiting the autoactivation of the CatK zymogen. Our results provide structural insights for the rational design of cyanohydrazide inhibitors of CatK as potential drugs.
组织蛋白酶 K(CatK)是治疗骨质疏松症、关节炎和骨转移的靶点。具有氰基酰肼弹头的肽模拟物代表了一类新型的高活性 CatK 抑制剂;然而,它们的结合机制尚不清楚。我们研究了两种具有不同定位弹头的模型氰基酰肼抑制剂:一种氮杂二肽腈和一种 3-氰基-3-氮杂-β-氨基酸。它们与成熟的 CatK 以及 CatK 的酶原样激活中间物的共价复合物的晶体结构已被确定。结合模式分析和量子化学计算表明,氮杂二肽腈的极高皮摩尔效力是由其在非启动-启动子亚基边界处的构象灵活性所带来的熵优势。此外,我们通过活细胞成像证明,氰基酰肼可有效靶向骨肉瘤细胞中的成熟 CatK。氰基酰肼还通过抑制 CatK 酶原的自动激活来抑制 CatK 的成熟。我们的结果为 CatK 的氰基酰肼抑制剂的合理设计提供了结构见解,有望成为潜在药物。